Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-01

FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Northstar Rx LLC.)

View source ↗

Summary

FDA approved a supplemental application for the Atenolol and Chlorthalidone fixed-dose combination from Northstar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATENOLOL AND CHLORTHALIDONE (Atenolol and chlorthalidone)

Snippet

SUPPL AP for ATENOLOL AND CHLORTHALIDONE (ATENOLOL AND CHLORTHALIDONE)